Abstract：【Objective】 To investigate the efficacy of irbesartan combined with enhanced external counterpulsation in the treatment of senile early diabetic nephropathy (DN) and its effect on endothelial cell function.【Methods】 A total of 90 elderly patients with early diabetic nephropathy treated in our hospital were selected and randomly divided into the control group(45 cases)and the observation group(45 cases). Patients in the control group received routine hypoglycemic and lipid-lowering treatment plus a daily 150 mg irbesartan administered orally. Meanwhile, the observation group was given enhanced external counterpulsation (once daily for 45 minutes) on the basis of the conventional treatment received by the control group.All patients were treated for 8 weeks. The changes of serum creatinine (Scr), blood urea nitrogen (BUN), microalbuminuria (MA), beta2 microglobulin (β2-MG), N acetyl D glucosamine enzyme (NAG), serum cystatin C (Cys-C), endothelin -1 (ET-1) and nitric oxide (NO) were compared between the two groups before and after treatment.【Results】 After treatment, the levels of SCr, BUN, MA, β2-MG, NAG, and Cys-C in the blood of both groups' patients were decreased; the decrease in the observation group was significantly lower than in the control group (P<0.05). The level of ET-1 in the observation group after treatment was significantly lower than that before treatment, and it was lower than that of the control group as well (P<0.05).The level of NO in the observation groups was significantly higher than that in the control group before treatment. The difference was statistically significant (P<0.05). 【Conclusion】 Irbesartan combining with enhanced external counterpulsation in the treatment of elderly patients with DN can effectively reduce the excretion of urinary protein and improve renal function.The mechanism may be related to the improvement of endothelial cell function.
刘春田, 王晓娟, 冯建军. 厄贝沙坦联合增强型体外反搏治疗老年早期糖尿病肾病的疗效观察[J]. 医学临床研究, 2018, 35(8): 1493-1495.
LIUChun-tian, WANGXiao-juan, FENGJian-jun. Efficacy of Irbesartan Combined with Enhanced External Counterpulsation in the Elderly Patients with Early Diabetic Nephropathy. JOURNAL OF CLINICAL RESEARCH, 2018, 35(8): 1493-1495.
[1] 谢席胜,艾娜,王宝福,等.糖尿病肾病流行病学进展[J].中国中西医结合肾病杂志,2013,14,(10):937-940. [2] Heiling CW,Deb DK,Abdul A,et al.GLUTl regulation of the pro-scle-rotic mediators of diabetic nephropathy[J].Am J Nephrol,2013,38(1):39-49. [3] Mogensen CE,Keane WF,Bennett PH,et al.Prevention of diabetic renal disease with special reference to microalbumin-uria[J].Lancet,1995,346(8982):1080-1084. [4] Parving HH,Tarnow L,Rossing P.Genetics of diatetic nephropathy[J].J Am Socl Nephol,1996,7(12):2509-2517. [5] Murkamilov IT,Sabirov IS,Fomin VV,et al.Endothelial dysfunction and arterial wall stiffness:New targets in diabetic nephropathy[J].Ter Arkh,2017,89(10):87-94. [6] Ivo RB,Kerstin L, Ferdinand LN, et al.Physics meets molecules is modulation of shear stress the link to vascular prevention [J]?Circ Res,2008,102(5):510-512. [7] Kinlay S,Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy[J].AM J Cardiol,1997,80(9A):111-161. [8] 刘永生. 内皮型一氧化氮合酶基因多态性与原发性高血压发病相关性的研究[D]. 吉林:吉林大学,2014. [9] 徐力,王会琴.早期糖尿病肾病患者血清胱抑素C及其他标志物与尿微量白蛋白相关性探讨[J].中国实用医刊,2011,38(15):119-121. [10] Yang DY, Wu GF. Vasculoprotective properties of enhanced external counterpulsation for coronary artery disease: beyond the hemodynamics[J].Int J Cardiol,2013,166( 1) : 38-43. [11] Caro CG.Discovery of the role of wall shear in atherosclerosis[J].Arterioscler Thromb Vasc Biol,2009,29( 29) : 158-161.
2018, Vol. 35 
